$IDPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOGEN INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOGEN INC.. Get notifications about new insider transactions in BIOGEN INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 09 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | Head of Research & ... | Sell | S | 440.00 | 7,672 | 3,375,680 | 10,169 | 17.8 K to 10.2 K (-43.00 %) |
Jun 09 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | Head of Research & ... | Sell | S | 440.00 | 7,672 | 3,375,680 | 10,169 | 17.8 K to 10.2 K (-43.00 %) |
Feb 22 2021 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | A | 0.00 | 45,310 | 0 | 45,310 | |
Feb 22 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | A | 0.00 | 14,500 | 0 | 14,500 | |
Feb 22 2021 | IDPH | BIOGEN INC. | MCDONNELL MICHAEL R | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 14,500 | 0 | 14,500 | |
Feb 22 2021 | IDPH | BIOGEN INC. | Kramer Robin | SVP, Chief Accounti ... | Option Exercise | A | 0.00 | 2,900 | 0 | 2,900 | |
Feb 22 2021 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Option Exercise | A | 0.00 | 14,500 | 0 | 14,500 | |
Feb 22 2021 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | A | 0.00 | 10,150 | 0 | 10,150 | |
Feb 22 2021 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Option Exercise | A | 0.00 | 10,870 | 0 | 10,870 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | J | 0.00 | 7,221 | 0 | 25,122 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,337 | 0 | 32,343 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | J | 0.00 | 7,263 | 0 | 12,526 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,259 | 0 | 19,789 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | J | 0.00 | 6,419 | 0 | 0 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,693 | 0 | 6,419 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Payment of Exercise | F | 278.03 | 2,367 | 658,097 | 52,969 | 55.3 K to 53 K (-4.28 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Payment of Exercise | F | 278.03 | 2,333 | 648,644 | 55,336 | 57.7 K to 55.3 K (-4.05 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Payment of Exercise | F | 278.03 | 2,525 | 702,026 | 57,669 | 60.2 K to 57.7 K (-4.19 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | M | 0.00 | 5,337 | 0 | 60,194 | 54.9 K to 60.2 K (+9.73 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | M | 0.00 | 5,259 | 0 | 54,857 | 49.6 K to 54.9 K (+10.60 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | M | 0.00 | 5,693 | 0 | 49,598 | 43.9 K to 49.6 K (+12.97 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Payment of Exercise | F | 278.03 | 7,248 | 2,015,161 | 43,905 | 51.2 K to 43.9 K (-14.17 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | J | 0.00 | 2,310 | 0 | 8,042 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | M | 0.00 | 1,708 | 0 | 10,352 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | J | 0.00 | 1,996 | 0 | 3,446 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | M | 0.00 | 1,446 | 0 | 5,442 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | J | 0.00 | 1,466 | 0 | 0 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | M | 0.00 | 1,300 | 0 | 1,466 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Payment of Exercise | F | 278.03 | 758 | 210,747 | 17,738 | 18.5 K to 17.7 K (-4.10 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Payment of Exercise | F | 278.03 | 642 | 178,495 | 18,496 | 19.1 K to 18.5 K (-3.35 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Payment of Exercise | F | 278.03 | 577 | 160,423 | 19,138 | 19.7 K to 19.1 K (-2.93 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Buy | M | 0.00 | 1,708 | 0 | 19,715 | 18 K to 19.7 K (+9.49 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Buy | M | 0.00 | 1,446 | 0 | 18,007 | 16.6 K to 18 K (+8.73 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Buy | M | 0.00 | 1,300 | 0 | 16,561 | 15.3 K to 16.6 K (+8.52 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Payment of Exercise | F | 278.03 | 1,533 | 426,220 | 15,261 | 16.8 K to 15.3 K (-9.13 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Option Exercise | J | 0.00 | 2,194 | 0 | 7,634 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Option Exercise | M | 0.00 | 1,622 | 0 | 9,828 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Option Exercise | J | 0.00 | 2,118 | 0 | 3,656 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Option Exercise | M | 0.00 | 1,534 | 0 | 5,774 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Payment of Exercise | F | 278.03 | 477 | 132,620 | 6,006 | 6.5 K to 6 K (-7.36 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Payment of Exercise | F | 278.03 | 463 | 128,728 | 6,483 | 6.9 K to 6.5 K (-6.67 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Buy | M | 0.00 | 1,622 | 0 | 6,946 | 5.3 K to 6.9 K (+30.47 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Buy | M | 0.00 | 1,534 | 0 | 5,324 | 3.8 K to 5.3 K (+40.47 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | J | 0.00 | 1,444 | 0 | 5,028 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | M | 0.00 | 1,068 | 0 | 6,472 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | J | 0.00 | 1,332 | 0 | 2,298 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | M | 0.00 | 964 | 0 | 3,630 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | J | 0.00 | 1,005 | 0 | 0 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | M | 0.00 | 891 | 0 | 1,005 | |
Feb 17 2021 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 278.03 | 474 | 131,786 | 7,990 | 8.5 K to 8 K (-5.60 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 278.03 | 428 | 118,997 | 8,464 | 8.9 K to 8.5 K (-4.81 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 278.03 | 396 | 110,100 | 8,892 | 9.3 K to 8.9 K (-4.26 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Buy | M | 0.00 | 1,068 | 0 | 9,288 | 8.2 K to 9.3 K (+12.99 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Buy | M | 0.00 | 964 | 0 | 8,220 | 7.3 K to 8.2 K (+13.29 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Buy | M | 0.00 | 891 | 0 | 7,256 | 6.4 K to 7.3 K (+14.00 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 278.03 | 884 | 245,779 | 6,365 | 7.2 K to 6.4 K (-12.19 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 0.00 | 1,367 | 0 | 6,434 | |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 0.00 | 1,367 | 0 | 6,434 | |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | J | 0.00 | 1,849 | 0 | 7,801 | |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | J | 0.00 | 1,849 | 0 | 7,801 | |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 0.00 | 1,402 | 0 | 3,344 | |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 0.00 | 1,402 | 0 | 3,344 | |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | J | 0.00 | 1,936 | 0 | 4,746 | |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | J | 0.00 | 1,936 | 0 | 4,746 | |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | J | 0.00 | 1,788 | 0 | 0 | |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | J | 0.00 | 1,788 | 0 | 0 | |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 0.00 | 1,586 | 0 | 1,788 | |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Option Exercise | M | 0.00 | 1,586 | 0 | 1,788 | |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 278.03 | 607 | 168,764 | 41,576 | 42.2 K to 41.6 K (-1.44 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 278.03 | 607 | 168,764 | 41,576 | 42.2 K to 41.6 K (-1.44 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 278.03 | 622 | 172,935 | 42,183 | 42.8 K to 42.2 K (-1.45 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 278.03 | 622 | 172,935 | 42,183 | 42.8 K to 42.2 K (-1.45 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 278.03 | 704 | 195,733 | 42,805 | 43.5 K to 42.8 K (-1.62 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 278.03 | 704 | 195,733 | 42,805 | 43.5 K to 42.8 K (-1.62 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 0.00 | 1,367 | 0 | 43,509 | 42.1 K to 43.5 K (+3.24 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 0.00 | 1,367 | 0 | 43,509 | 42.1 K to 43.5 K (+3.24 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 0.00 | 1,402 | 0 | 42,142 | 40.7 K to 42.1 K (+3.44 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 0.00 | 1,402 | 0 | 42,142 | 40.7 K to 42.1 K (+3.44 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 0.00 | 1,586 | 0 | 40,740 | 39.2 K to 40.7 K (+4.05 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Buy | M | 0.00 | 1,586 | 0 | 40,740 | 39.2 K to 40.7 K (+4.05 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 278.03 | 1,963 | 545,773 | 39,154 | 41.1 K to 39.2 K (-4.77 %) |
Feb 17 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Payment of Exercise | F | 278.03 | 1,963 | 545,773 | 39,154 | 41.1 K to 39.2 K (-4.77 %) |
Feb 10 2021 | IDPH | BIOGEN INC. | Mantas Jesus B | Director | Buy | P | 267.00 | 898 | 239,766 | 2,943 | 2 K to 2.9 K (+43.91 %) |
Jan 29 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Grant | A | 0.00 | 4,545 | 0 | 41,117 | 36.6 K to 41.1 K (+12.43 %) |
Jan 29 2021 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP Chief Legal Off ... | Grant | A | 0.00 | 4,545 | 0 | 41,117 | 36.6 K to 41.1 K (+12.43 %) |
Jan 29 2021 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Grant | A | 0.00 | 818 | 0 | 3,445 | 2.6 K to 3.4 K (+31.14 %) |
Jan 29 2021 | IDPH | BIOGEN INC. | Galdes Alphonse | EVP Pharmaceutical ... | Grant | A | 0.00 | 818 | 0 | 3,445 | 2.6 K to 3.4 K (+31.14 %) |
Jan 29 2021 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Grant | A | 0.00 | 2,558 | 0 | 7,249 | 4.7 K to 7.2 K (+54.53 %) |
Jan 29 2021 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Grant | A | 0.00 | 2,558 | 0 | 7,249 | 4.7 K to 7.2 K (+54.53 %) |
Jan 29 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Grant | A | 0.00 | 3,728 | 0 | 16,794 | 13.1 K to 16.8 K (+28.53 %) |
Jan 29 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Grant | A | 0.00 | 3,728 | 0 | 16,794 | 13.1 K to 16.8 K (+28.53 %) |
Jan 29 2021 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Grant | A | 0.00 | 16,343 | 0 | 51,153 | 34.8 K to 51.2 K (+46.95 %) |
Dec 07 2020 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Option Exercise | J | 0.00 | 102 | 0 | 178 | |
Dec 07 2020 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 74 | 0 | 280 | |
Dec 07 2020 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Payment of Exercise | F | 244.09 | 22 | 5,370 | 373 | 395 to 373 (-5.57 %) |
Dec 07 2020 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Buy | M | 0.00 | 74 | 0 | 395 | 321 to 395 (+23.05 %) |
Dec 03 2020 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Option Exercise | J | 0.00 | 693 | 0 | 0 | |
Dec 03 2020 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Option Exercise | M | 0.00 | 481 | 0 | 693 | |
Dec 03 2020 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Payment of Exercise | F | 243.16 | 214 | 52,036 | 3,790 | 4 K to 3.8 K (-5.34 %) |
Dec 03 2020 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Buy | M | 0.00 | 481 | 0 | 4,004 | 3.5 K to 4 K (+13.65 %) |
Dec 03 2020 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Payment of Exercise | F | 243.16 | 348 | 84,620 | 3,523 | 3.9 K to 3.5 K (-8.99 %) |
Dec 01 2020 | IDPH | BIOGEN INC. | Vounatsos Michel | Chief Executive Off ... | Buy | P | 241.31 | 3,100 | 748,047 | 34,810 | 31.7 K to 34.8 K (+9.78 %) |
Nov 06 2020 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Sell | S | 350.00 | 1,500 | 525,000 | 13,066 | 14.6 K to 13.1 K (-10.30 %) |
Sep 03 2020 | IDPH | BIOGEN INC. | MCDONNELL MICHAEL R | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 16,090 | 0 | 16,090 | |
Sep 03 2020 | IDPH | BIOGEN INC. | MCDONNELL MICHAEL R | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 8,045 | 0 | 8,045 | |
Aug 04 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | J | 0.00 | 216 | 0 | 0 | |
Aug 04 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | M | 0.00 | 212 | 0 | 216 | |
Aug 04 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 274.69 | 95 | 26,096 | 4,691 | 4.8 K to 4.7 K (-1.98 %) |
Aug 04 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Buy | M | 0.00 | 212 | 0 | 4,786 | 4.6 K to 4.8 K (+4.63 %) |
Aug 04 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 274.69 | 128 | 35,160 | 4,574 | 4.7 K to 4.6 K (-2.72 %) |
Jul 06 2020 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Option Exercise | A | 0.00 | 755 | 0 | 755 | |
Jun 05 2020 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Grant | A | 0.00 | 890 | 0 | 16,328 | 15.4 K to 16.3 K (+5.76 %) |
Jun 05 2020 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Grant | A | 0.00 | 890 | 0 | 17,069 | 16.2 K to 17.1 K (+5.50 %) |
Jun 05 2020 | IDPH | BIOGEN INC. | Posner Brian S | Director | Grant | A | 0.00 | 890 | 0 | 7,885 | 7 K to 7.9 K (+12.72 %) |
Jun 05 2020 | IDPH | BIOGEN INC. | PAPADOPOULOS STELIOS | Director | Grant | A | 0.00 | 1,470 | 0 | 6,565 | 5.1 K to 6.6 K (+28.85 %) |
Jun 05 2020 | IDPH | BIOGEN INC. | PANGIA ROBERT W | Director | Grant | A | 0.00 | 890 | 0 | 20,632 | 19.7 K to 20.6 K (+4.51 %) |
Jun 05 2020 | IDPH | BIOGEN INC. | Mulligan Richard | Director | Grant | A | 0.00 | 890 | 0 | 12,954 | 12.1 K to 13 K (+7.38 %) |
Jun 05 2020 | IDPH | BIOGEN INC. | Mantas Jesus B | Director | Grant | A | 0.00 | 890 | 0 | 2,045 | 1.2 K to 2 K (+77.06 %) |
Jun 05 2020 | IDPH | BIOGEN INC. | LEAMING NANCY | Director | Grant | A | 0.00 | 890 | 0 | 12,988 | 12.1 K to 13 K (+7.36 %) |
Jun 05 2020 | IDPH | BIOGEN INC. | HAWKINS WILLIAM A | Director | Grant | A | 0.00 | 890 | 0 | 2,045 | 1.2 K to 2 K (+77.06 %) |
Jun 05 2020 | IDPH | BIOGEN INC. | DORSA CAROLINE | Director | Grant | A | 0.00 | 890 | 0 | 21,097 | 20.2 K to 21.1 K (+4.40 %) |
Jun 05 2020 | IDPH | BIOGEN INC. | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 890 | 0 | 12,954 | 12.1 K to 13 K (+7.38 %) |
Mar 12 2020 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Option Exercise | M | 59.82 | 1,355 | 81,056 | 0 | |
Mar 12 2020 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Option Exercise | M | 59.82 | 10,923 | 653,414 | 0 | |
Mar 12 2020 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Sell | S | 295.29 | 270 | 79,728 | 15,438 | 15.7 K to 15.4 K (-1.72 %) |
Mar 12 2020 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Buy | M | 58.46 | 1,355 | 79,213 | 15,708 | 14.4 K to 15.7 K (+9.44 %) |
Mar 12 2020 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Sell | S | 295.22 | 2,164 | 638,845 | 14,353 | 16.5 K to 14.4 K (-13.10 %) |
Mar 12 2020 | IDPH | BIOGEN INC. | SHERWIN STEPHEN A | Director | Buy | M | 58.46 | 10,923 | 638,559 | 16,517 | 5.6 K to 16.5 K (+195.26 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Option Exercise | A | 0.00 | 1,510 | 0 | 1,510 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Option Exercise | J | 0.00 | 154 | 0 | 574 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 132 | 0 | 728 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Payment of Exercise | F | 331.76 | 46 | 15,261 | 236 | 282 to 236 (-16.31 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Kramer Robin | VP, Chief Accountin ... | Buy | M | 0.00 | 132 | 0 | 282 | 150 to 282 (+88.00 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Karp Daniel | EVP, Corporate Deve ... | Option Exercise | A | 0.00 | 6,030 | 0 | 6,030 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Karp Daniel | EVP, Corporate Deve ... | Option Exercise | J | 0.00 | 1,126 | 0 | 4,174 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Karp Daniel | EVP, Corporate Deve ... | Option Exercise | M | 0.00 | 960 | 0 | 5,300 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Karp Daniel | EVP, Corporate Deve ... | Payment of Exercise | F | 331.76 | 294 | 97,537 | 930 | 1.2 K to 930 (-24.02 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Karp Daniel | EVP, Corporate Deve ... | Buy | M | 0.00 | 960 | 0 | 1,224 | 264 to 1.2 K (+363.64 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Option Exercise | A | 0.00 | 11,450 | 0 | 11,450 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Option Exercise | J | 0.00 | 1,972 | 0 | 7,308 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Option Exercise | M | 0.00 | 1,680 | 0 | 9,280 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Payment of Exercise | F | 331.76 | 504 | 167,207 | 3,871 | 4.4 K to 3.9 K (-11.52 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Guindo Chirfi | EVP Glob. Prod Stra ... | Buy | M | 0.00 | 1,680 | 0 | 4,375 | 2.7 K to 4.4 K (+62.34 %) |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | A | 0.00 | 7,540 | 0 | 7,540 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | J | 0.00 | 1,240 | 0 | 4,594 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | M | 0.00 | 1,056 | 0 | 5,834 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | J | 0.00 | 918 | 0 | 1,896 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | M | 0.00 | 974 | 0 | 2,814 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Option Exercise | M | 0.00 | 1,517 | 0 | 0 | |
Feb 14 2020 | IDPH | BIOGEN INC. | Gregory Ginger | EVP, Human Resource ... | Payment of Exercise | F | 331.76 | 418 | 138,676 | 4,603 | 5 K to 4.6 K (-8.33 %) |